Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial

BACKGROUND: Prostate cancer (PC) incidence rates vary 25-fold worldwide. Differences in PSA screening are largely, but not entirely, responsible. We examined geographic differences in prevalence of histologic prostate inflammation and subsequent PC risk. METHODS: 7,000 non-Hispanic white men were en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Epidemiol Biomarkers Prev
Autores principales: Allott, Emma H., Markt, Sarah C., Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Mucci, Lorelei A., Freedland, Stephen J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035080/
https://ncbi.nlm.nih.gov/pubmed/29669727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-0076
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares